Abstract:
Antibiotics are commonly overused to treat upper respiratory tract infections
(URTIs) in HIV-infected adults, even though viruses cause most URTIs.
Therefore, antibiotic overuse for URTIs is considered an unwarranted and
unnecessary practice, which needs to be de-implemented. Thus, the goal of
this thesis is to evaluate the effectiveness and implementation of a clinical
decision support algorithm (CDSA) to de-implement unnecessary antibiotic
prescriptions among HIV-infected adults with URTI symptoms in primary
healthcare facilities. The thesis comprises a total of four studies, culminating
in five manuscripts. Study I (Paper I) aimed to explore and describe antibiotic
prescribing for HIV-infected patients in primary healthcare facilities, using a
cross-sectional design. Antibiotics were prescribed in 65.9% of prescriptions,
either for treatment (69.8%) or prophylaxis (30.2%) of infections, and most
were indicated for respiratory tract infections (30.5%). Study II (Paper III)
aimed to explore the context of readiness for implementing the intervention
in selected healthcare facilities, using a cross-sectional design with a
mixed-methods approach. Thirty-nine healthcare providers (HCPs) among
clinicians, laboratory technicians, and pharmacists were interviewed. Over
50% of clinicians did not possess or use any clinical guideline/algorithm,
and 92.6% reported using clinical diagnosis alone to determine the choice
in antibiotic use. All study facilities reported limited laboratory capacity
to aid evidence to clinicians in antibiotic prescribing. HCPs described
enthusiasm and willingness to utilize a new CDSA intervention. The lack
of existing decision-support tools and limitations in laboratory diagnostic
support justified the introduction of our CDSA, and the HCPs’ enthusiasm
and willingness supported their readiness. Study III (Papers II and IV) aimed
to evaluate the effectiveness of the intervention on reducing unnecessary
antibiotic prescriptions for URTIs among HIV-infected adults, using a two-
arm cluster randomized controlled trial design. Three hundred seventy-nine
patients were recruited, comprising 182 (48%) in the intervention group and
197 (52%) in the control group. Most appeared with common cold and flu-
like symptoms. The intervention was associated with a significant reduction
in antibiotic prescribing by 33.2% (p < 0.001) and a non-significant decrease
in incidence of complications by 3.7% (p = 0.096). In both groups, most
patients (78%) recovered completely within five days. Amoxicillin (47.8%),
azithromycin (21.9%), and phenoxymethylpenicillin (14.1%) were the most
prescribed antibiotics. Study IV (Paper V) aimed to evaluate implementation
outcomes of the intervention using the RE-AIM framework, employing a
hybrid type II effectiveness-implementation design. Among 387 HIV-infected
iv
7
adults approached, 379 (97.9%) were successfully recruited, with 182 (48%)
in the intervention and 197 (52%) in the control group. Among the recruited
patients, the mean age was 44±12.3 years, and 286 (75.5%) were female. The
intervention resulted in 33.2% fewer antibiotics prescribed compared to the
control. All intervention sites (100%) and clinicians (100%) demonstrated a
commitment to de-implementing antibiotics. The implementation protocol
was delivered as planned, and participants (n=21) in focus group discussions
(FGD) were satisfied with the intervention. The evidence presented in this
thesis may support clinicians and decision makers in their efforts for rational
antibiotic use in managing URTIs in primary healthcare facilities